Back to Search
Start Over
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
- Source :
-
Archives of dermatological research [Arch Dermatol Res] 2022 Oct; Vol. 314 (8), pp. 805-808. Date of Electronic Publication: 2021 Mar 27. - Publication Year :
- 2022
-
Abstract
- Statins have been associated with an increased risk of keratinocyte carcinoma but data are limited and conflicting. Statins are hypothesized to contribute to KC through immunomodulation. A whole-population case-control study of the Icelandic population was conducted using the Icelandic Cancer Registry and Icelandic Prescription Medicine Register. These are high-quality registers which include all cancer diagnoses, as well as every prescription in the country. Cases included all first-time histologically confirmed diagnoses of (BCC), in situ squamous cell carcinoma (SCCis) and invasive SCC between 2003 and 2017. Each case was paired with 10 age- and sex-matched controls. Multivariate conditional logistic regression analysis was performed. Four thousand seven hundred patients with BCC, 1167 patients with SCCis and 1013 patients with invasive SCC were identified and paired with 47,292, 11,961 and 10,367 controls, respectively. Overall statin use was associated with an increased risk of invasive SCC and SCCis but not BCC (adjusted OR [95% CI]: 1.29 [1.11-1.50]; 1.43 [1.24-1.64]; 1.03 [0.95-1.12], respectively). Subgroup analysis demonstrated that statins were significantly associated with invasive SCC and SCCis in patients over 60, but not in those under 60. Atorvastatin was only associated with an increased risk of SCCis; whereas, simvastatin was associated with an increased risk of both invasive SCC and SCCis. This whole-population study of Iceland demonstrates that statin exposure is associated with increased risk of SCC, but not BCC, in a low UV environment. The reasons are unclear, but our results may suggest that individuals receiving atorvastatin and simvastatin have differing levels of baseline keratinocyte cancer risk or that properties of a statin other than 'statin intensity' affect association with SCC.<br /> (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Subjects :
- Atorvastatin
Case-Control Studies
Humans
Iceland epidemiology
Simvastatin
Carcinoma, Basal Cell pathology
Carcinoma, Squamous Cell epidemiology
Carcinoma, Squamous Cell pathology
Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects
Skin Neoplasms chemically induced
Skin Neoplasms epidemiology
Skin Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1432-069X
- Volume :
- 314
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Archives of dermatological research
- Publication Type :
- Academic Journal
- Accession number :
- 33772628
- Full Text :
- https://doi.org/10.1007/s00403-021-02227-w